Upload
cornelia-morgan
View
217
Download
1
Tags:
Embed Size (px)
Citation preview
INTERNATIONAL CONFERENCE ON
ADVANCED TREATMENT OFCOLON CANCER
Improving treatment of colon cancer.
What is essential?
JUNE 9.- 10. 2011 BERGEN, NORWAY
Can the success of TME for rectal cancer be emulated by CME (complete mesocolic excision)?
The University of Bergen, Dept. of Surgical Sciences, and Haraldsplass Deaconal Hospital, Department of Surgery, invite you to learn about the concept of radical colon cancer surgery and treatment from world class speakers.
Organising committee: Professor dr. med. Karl Sø[email protected]
Dr. med. Kari [email protected]
The full course is registered for 16 hours. Fee: NOK 3200 (300 €)
Practical information, registration form and hotel accommodation is available online at: http://colon.axacoevent.se/en/registration
Pre- and post-congressional tours will also be available.
We are delighted to invite you to the beautiful World Heritage City of Bergen and look forward to seeing you in Bergen in June.
Venue: VilVite – Bergen Science CentreThormøhlensgate 515006 Bergen
PROGRAM - BERGEN JUNE 9 - 10, 2011Improving treatment of colon cancer. What is essential?
THURSDAY, JUNE 9Moderators Torbjörn Holm and Karl Søndenaa
08.15 Introduction. Karl Søndenaa08.30 Resectional approach for colon and rectosigmoid
cancer based on anatomy and lymphatic spread. Werner Hohenberger
09.00 The Japanese approach to colon cancer resections based on the vascular anatomy of the colon andrectosigmoid. Kenichi Sugihara
09.30 Turnbull’s good results in view of today’s concept of mesocolon and the central tie. Defining the surgical approach. Feza Remzi
10.00 Coffee break10.30 Differences between open and laparoscopic
surgery? Kristian Storli11.00 When is the laparoscopic approach permissible?
Kenichi Sugihara11.30 Discussion
12.00-13.00 Lunch
Moderators Arild Nesbakken and Werner Hohenberger
13.00 Overview of the radical colon cancer surgery project in Bergen. Karl Søndenaa
13.30 Background data from the Stockholm region colon project. Torbjørn Holm
13.45 Recent experience with the Stockholm region colon project. Richard Bernhoff
14.00 Discussion14.30 Coffee break15.00 Adequate treatment of rectosigmoid cancer.
Heinz Becker15.30 Size of specimen with CME evaluation, lymph node
numbers, LNR and other specific issues for the pathologist to decide. Nick West
16.00 Are micrometastases crucial to staging and survival? Arne Færden
16.20–17.00 Discussion
FRIDAY, June 10Moderators Werner Hohenberger and Feza Remzi
08.30 Should pulmonary CRC metastases be resected? Tom Treasure
09.00 The treatment of hepatic, pulmonary and cerebral CRC metastases in Western Norway. Lessons
for the colorectal surgeon. Arild Horn, Bjarte Hjelmeland and P-H Pedersen
09.30 The need for adjuvant chemotherapy. Is it evidence based and when? Halfdan Sørbye
09.45 Discussion10.00 Coffee break10.30 Treatment strategies for colon cancer at TNM
stage IV. Gunnar Arbman 11.00 HIPEC treatment of intra-abdominal
recurrence. Stein G. Larsen11.20 Discussion
12.00–13.00 Lunch
Moderators Torbjörn Holm and Karl Søndena
13.00 Lessons learned past and present in Oslo. Ole Sjo
13.15 Treatment of colon cancer in Northern Norway. Long distances - any significance for the patient and who should treat him?
Rolv-Ole Lindsetmo13.30 Prognosis of colon cancer compared with
rectal cancer. Where lies the difference. Bjørn Nedrebø
13.45 Recent trends in colorectal cancer in Norway: incidence, management, and outcome.Arne Wibe
14.00 Coffee break14.30 Morbidity and mortality after introduction of
radical colon cancer surgery. Bjørg Furnes
Panel debate:14.45 Why do some achieve better results? Is the
surgeon, hospital or dedication crucial? Werner Hohenberger
15.00 What can the Japanese experience teach others? Professor Kenichi Sugihara
15.15 Current teaching in the US. Feza Remzi15.30–16.00 Closing remarks and discussion